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The ability to induce degradation of a protein of interest is a powerful experimental tool used to ascertain
protein function. Iwamoto et al. (2010) describe a method that allows reversible and dose-dependent
modulation of the stability of any target protein.The best way to determine the function of
an uncharacterized protein in a cell is to
remove it and see what happens. The
most common ways to do this are to
disrupt expression of the gene encoding
the protein by altering the gene at the
DNA level or to manipulate mRNA levels
by RNA interference. However, these
techniques have the limitation that some
proteins persist in the cell for a long time
after their synthesis is blocked. Thus, it
would be useful to have a way to directly
eliminate individual proteins from cells.
Physiologically, proteins are most often
removed from the cell by the ubiquitin-
proteasome system (UPS). At the center
of this system is a large protease complex
called the proteasome. Individual sub-
strates are tagged for destruction by a
removable protein tag called ubiquitin,
which is attached by a cascade of
enzymes consisting of an E1 (ubiquitin-
activating enzyme), an E2 (ubiquitin-conju-
gating enzyme), and an E3 (ubiquitin-
protein ligase). Several methods have
been developed to redirect the UPS to
remove desired target proteins artificially.
Each approach has its own advantages
and disadvantages, but none has yet
seen widespread usage. In this issue, Iwa-
moto et al. (2010) present a new technique
that uses a small molecule to specifically
modulate the stability of, in principle, any
protein of interest. Because this technique
has several advantages over the existing
methods, it has the potential to become
widely employed.
In one class of approaches to degrade
a protein of interest, the ubiquitination
machinery is redirected to the new target.
For example, there is a ubiquitination
signal or degron that only becomes active
at high temperatures; when this degron is
fused to a target protein, degradation can
be induced by an increase in temperature
(Dohmen et al., 1994). Alternatively, onecan retarget ubiquitinating enzymes by
fusing them to a domain that specifically
recognizes the desired substrate (re-
viewed in Banaszynski and Wandless
(2006)). The target protein then becomes
ubiquitinated and is degraded. In a
particularly sophisticated version of this
method, the ubiquitination machinery is
redirected by a small molecule that binds
both the protein of interest and an E3 (Sa-
kamoto et al., 2001). The advantages of
this are that it does not require any gene
modification and it is inducible by a small
molecule, which also means that this
method could potentially be used thera-
peutically to remove undesirable proteins.
It is not always easy to find a ligand that
binds the target protein. To get around
this restriction, another method uses the
plant hormone auxin to bring the protein
of interest to an E3 complex. Auxin binds
both to a plant E3 and to a protein
receptor, which can be fused to the target
protein (Nishimura et al., 2009); auxin
addition then leads to ubiquitination and
degradation of the desired substrate.
Auxin is not found in mammalian cells
and so it does not have off-target effects,
but both the auxin-binding E3 component
and the modified protein of interest have
to be introduced into cells.
A second class of methods works by
directly relocating proteins in the cell. In
the examples developed to date, this is
done through an inducible dimerization
system based on the small molecule
rapamycin, which causes the two proteins
FKBP and mTOR to bind to each other
(reviewed in Crabtree and Schreiber
(1996)). If the rapamycin-binding domain
of mTOR, called FRB, is fused to the
target protein and FKBP is attached to a
subunit of the proteasome, then addition
of rapamycin will cause the target protein
to bind to the proteasome and be
degraded (Janse et al., 2004). ProteinsChemistry & Biology 17, September 24, 2010can also be inactivated by sequestration.
When FKBP is fused to a target protein
and FRB is attached to a mitochondrial
import signal, the addition of rapamycin
causes the target protein to be very
rapidly localized to mitochondria, which
inactivates it (Robinson et al., 2010).
The third and last class of approaches
works somewhat differently; here, the
target protein is first destabilized so that
it is constitutively degraded until it is
rescued by drug treatment. This approach
requires the protein of interest to be fused
to a destabilizing domain (DD), which
targets it for degradation. The protein
can then be rescued by the addition of a
ligand that binds the DD and inactivates
it. The system is reversible, and when
the ligand is withdrawn, the protein is
degraded again. In one implementation
of this approach, the DD is a mutant
version of the FRB domain. The FRB
fusion is stabilized by a rapamycin analog,
which induces dimerization with endoge-
nous FKBP. This method can be very
effective and has been used to create
conditional alleles in mice (Stankunas
et al., 2003). However, there are also
drawbacks; for example, the stabilized
target protein is part of a fairly large
complex whose bulk and geometry may
affect its function. It is possible to modify
the FRB and FKBP domains so that
rapamycin addition causes release of the
target protein in its native form, without
additional domains, but this also means
that stabilization can no longer be
reversed (Pratt et al., 2007).
In this issue, Iwamoto et al. (2010)
describe the development of a new DD
with superior properties. This DD is
derived from E. coli dihydrofolate reduc-
tase (ecDHFR) and is stabilized by the
DHFR inhibitor trimethoprim (TMP). Iwa-
moto et al. (2010) isolated the ecDHFR
mutants used as DDs in a cell-basedª2010 Elsevier Ltd All rights reserved 917
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almost complete removal of the fusion
protein. TMP stabilizes the DD-target pro-
tein fusion in a dose-dependent manner
up to 100-fold, which gives the system
a substantial dynamic range. Stabilization
is reversible and removal of TMP leads
to rapid degradation back to background
levels. In addition, the ligand TMP works
by itself and does not require dimerization
with a second protein, similar to an earlier
version developed by the same group
(Banaszynski et al., 2006). This system
appears to be so effective that it can
even control the levels of transmembrane
proteins, which greatly increases its
potential utility and applicability.
The stabilizing ligand used for this
system also brings some important
practical advantages. TMP is commer-
cially available, inexpensive, and has
good pharmacological properties, which
makes its usage in in vivo experimental
systems easier. TMP has very few off-
target effects inmammalian cells because
it inhibits ecDHFR much more strongly
than the endogenous mammalian DHFR.
In fact, it is used as an antibiotic. Addition-918 Chemistry & Biology 17, September 24, 2ally, TMP crosses the blood-brain barrier
and can therefore be used to modulate
the stability of proteins in the central
nervous system of live animals. Finally,
TMP also crosses the placental barrier,
which should permit the study of proteins
that are essential in the earliest stages of
development. If the offspring contain
a gene modified with ecDHFR, TMP could
be administered to the mother throughout
gestation to ensure the presence of the
protein of interest. At the desired times,
TMP could then be withdrawn so that
the target protein is degraded. This would
make it possible to investigate the role of
the targeted protein at various stages of
development.
Thus, the new ecDHFR-derived DD
method represents a substantial step
forward for inducible protein degradation
systems, and it could become a practical
addition to our tools for regulating protein
concentrations.REFERENCES
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High redox potential laccases fromwhite-rot fungi are recalcitrant to engineering. Mate´ et al. (2010) employed
directed evolution to improve the activity and expression level of the fungal laccase frombasidiomycete PM1,
followed by rational design to restore thermostability lost during evolution, resulting in a highly active and
stable enzyme.Highly active and stable enzymes are
desirable for industrial biotechnology.
Two methods are commonly used to
obtain enzymes with such properties:
screening microorganisms to identify
novel enzymes, and engineering existing
enzymes to improve these properties.
While traditional strain screening is
still widely used, enzyme engineering, in
particular directed-enzyme evolution,has increasingly become an alternative
to generate enzymes with desired proper-
ties. This is particularly true when enzyme
properties, such as enzymatic activity
and thermal stability, can be analyzed in
a high throughput manner to facilitate the
identification of superior mutants from
fairly large mutant libraries. In a typical
directed-evolution experiment, screening
for enhanced enzymatic activity is per-formed concomitantly with screening
for improved thermostability to generate
mutants that are both more active and
more stable. With such a procedure,
some mutants with enhanced activity
but less stability are obtained, while
others with enhanced stability but less
activity are also frequently identified. If
the additive mutations fail to be com-
bined, either the more active mutant or
